Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy for Graves' ophthalmopathy].

Jianguo Zheng1, Xia Zhang, Rixiang Gong

  • 1Department of Nuclear Medicine, Beijing Hospital, Beijing, 610041, China.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi
|November 24, 2004
PubMed
Summary

Graves' ophthalmopathy (GO), a thyroid-related eye disease, affects 5-10% of hyperthyroidism patients. This review explores developing therapies and future treatment trends for this challenging condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the NAD<sup>+</sup> salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level.

Cell communication and signaling : CCS·2020
Same author

Complex reconstruction technique applied in advanced head and neck cancer.

Medicine·2020
Same author

A Phytophthora capsici effector suppresses plant immunity via interaction with EDS1.

Molecular plant pathology·2020
Same author

Development and evaluation of a panel of multiplex one-tube nested real time PCR assay for simultaneous detection of 14 respiratory viruses in five reactions.

Journal of medical virology·2020
Same author

Maternal cigarette smoke exposure disturbs glutamate/GABA balance in pFRG of neonatal rats.

Respiratory physiology & neurobiology·2020
Same author

Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.

Oncotarget·2020

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Immunology

Context:

  • Graves' ophthalmopathy (GO), also known as thyroid-related eye disease, is an autoimmune condition linked to thyroid autoimmunity, particularly hyperthyroidism.
  • GO affects 5-10% of hyperthyroidism patients, with higher incidence in males than females.
  • Treating severe GO is challenging, with often unsatisfactory therapeutic outcomes.

Purpose:

  • To review the development of therapeutic methods for Graves' ophthalmopathy.
  • To discuss current treatment strategies and their limitations.
  • To prospect future trends in GO therapy.

Summary:

  • This review introduces the evolution of therapies for Graves' ophthalmopathy (GO).
  • It highlights the ongoing research and development of novel therapeutic approaches to address the difficulties in treating severe GO.

Related Experiment Videos

  • The paper also provides an outlook on the future trends in GO treatment.

    • Impact:

    • This review aims to inform clinicians and researchers about the progress in GO treatment.
    • It may guide the development of more effective therapies for patients with severe Graves' ophthalmopathy.
    • Understanding treatment trends can lead to improved patient outcomes and management strategies.